Deciphering the molecular mechanisms underlying anti-pathogenic potential of a polyherbal formulation Enteropan®

Sweety Parmar1, Gemini Gajera1, Nidhi Thakkar1

  • 1Institute of Science, Nirma University, Ahmedabad - India.

Drug Target Insights
|September 3, 2024
PubMed
Abstract

Insights

The polyherbal formulation Enteropan® reduces virulence in multidrug-resistant Pseudomonas aeruginosa by over 70%. This natural compound targets key bacterial mechanisms, offering a promising avenue for combating antibiotic resistance.

Area of Science:

  • Microbiology
  • Pharmacology
  • Genomics

Background:

  • Multidrug-resistant (MDR) *Pseudomonas aeruginosa* poses a significant threat in healthcare settings.
  • There is a critical need for novel anti-pathogenic strategies beyond traditional antibiotics.

Purpose of the Study:

  • To investigate the anti-pathogenic potential of the polyherbal formulation Enteropan® against MDR *P. aeruginosa*.
  • To elucidate the molecular mechanisms underlying Enteropan®'s anti-virulence activity.

Main Methods:

  • *In vitro* assays were used to assess bacterial growth, pigment production, and antibiotic susceptibility.
  • Virulence was evaluated using the nematode *Caenorhabditis elegans* model.
  • Whole transcriptome analysis identified molecular targets and pathways affected by Enteropan®.

Main Results:

  • Enteropan® pre-exposure reduced *P. aeruginosa* virulence in *C. elegans* by approximately 70%.
  • The formulation modulated biofilm formation, protein secretion, pigment production, and antibiotic susceptibility.
  • Transcriptome analysis revealed differential expression in 17% of the *P. aeruginosa* genome, highlighting nitrosative stress, oxidative stress, and quorum sensing as key affected mechanisms.

Conclusions:

  • Enteropan® effectively attenuates the virulence of MDR *P. aeruginosa* through multiple molecular mechanisms.
  • The bacterium did not develop complete resistance to Enteropan® after repeated exposure.
  • Identified potential drug targets, such as *rpoA*, *tig*, *rpsB*, *rpsL*, and *rpsJ*, warrant further investigation for drug discovery programs.

Related Concept Videos

Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
951
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.8K